Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell lineTadashi Ashizawa, Ken Yamaguchi|International Journal of Oncology|2014Cited by 40
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell lineYasuto Akiyama, Ken Yamaguchi|Oncology Reports|2014Cited by 36